Pain Therapeutic Injectables Market Size, Share, Growth, and Industry Analysis, By Types (OTC Products, Prescription Drugs, ), By Applications (Hospital Pharmacies, Specialty Clinics, Long Term Care Centers, Retail Pharmacies, Drug Stores, Online Pharmacies, ) , and Regional Insights and Forecast to 2035

Last Updated: 21-April-2026
Base Year: 2025
Historical Data: 2021-2024

Region: Global
Format: PDF
Report ID: GGI125219
SKU ID: 30551738
Pages: 114

Download FREE Sample

Buy Now - USD 3,580

1000+

GLOBAL LEADERS TRUST US

Table of Content

1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Pain Therapeutic Injectables Market Size

1.3 Market Segmentation

1.4 Regulatory Environment

2 Industry Chain Analysis

2.1 Industry Chain Analysis

2.2 Pain Therapeutic Injectables Raw Materials Analysis

2.2.1 Key Raw Materials Introduction

2.2.2 Key Suppliers of Raw Materials

2.3 Pain Therapeutic Injectables Business Mode and Production Process

2.3.1 Pain Therapeutic Injectables Business Mode Analysis

2.3.2 Production Process Analysis

2.4 Pain Therapeutic Injectables Cost Structure Analysis

2.4.1 Manufacturing Cost Structure of Pain Therapeutic Injectables

2.4.2 Raw Material Cost of Pain Therapeutic Injectables

2.4.3 Labor Cost of Pain Therapeutic Injectables

2.5 Market Channel Analysis

2.6 Major Downstream Customers Analysis

2.7 Alternative Product Analysis

3 Market Dynamics

3.1 Market Drivers

3.2 Market Constraints and Challenges

3.3 Emerging Market Trends

3.4 PESTEL Analysis

3.5 Consumer Insights Analysis

3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape

4.1 Global Pain Therapeutic Injectables Revenue and Market Share by Manufacturer (2021-2026)

4.2 Global Pain Therapeutic Injectables Sales Volume and Market Share by Manufacturer (2021-2026)

4.3 Global Pain Therapeutic Injectables Price by Manufacturer (2021-2026)

4.4 Pain Therapeutic Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

4.5 Global Key Manufacturers of Pain Therapeutic Injectables, Manufacturing Base Distribution and Headquarters

4.6 Global Key Manufacturers of Pain Therapeutic Injectables, Product Offered and Application

4.7 Pain Therapeutic Injectables Market Competitive Situation and Trends

4.7.1 Pain Therapeutic Injectables Market Concentration Rate

4.7.2 Global Top 3 and Top 6 Pain Therapeutic Injectables Players Market Share by Revenue

4.8 Industry News

4.8.1 Key Product Launch News

4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Pain Therapeutic Injectables Market Historical Development by Geographic Region (2021-2026)

5.1 Global Pain Therapeutic Injectables Market Historical Sales Volume by Geographic Region (2021-2026)

5.2 Global Pain Therapeutic Injectables Market Historical Revenue by Geographic Region (2021-2026)

5.3 North America Pain Therapeutic Injectables Market Status by Country (2021-2026)

5.3.1 North America Pain Therapeutic Injectables Sales Volume by Country (2021-2026)

5.3.2 North America Pain Therapeutic Injectables Revenue by Country (2021-2026)

5.3.3 United States Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.3.4 Canada Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.4 Europe Pain Therapeutic Injectables Market Status by Country (2021-2026)

5.4.1 Europe Pain Therapeutic Injectables Sales Volume by Country (2021-2026)

5.4.2 Europe Pain Therapeutic Injectables Revenue by Country (2021-2026)

5.4.3 Germany Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.4.4 France Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.4.5 United Kingdom Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.4.6 Spain Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.4.7 Russia Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.4.8 Poland Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.5 Asia Pacific Pain Therapeutic Injectables Market Status by Country (2021-2026)

5.5.1 Asia Pacific Pain Therapeutic Injectables Sales Volume by Country (2021-2026)

5.5.2 Asia Pacific Pain Therapeutic Injectables Revenue by Country (2021-2026)

5.5.3 China Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.5.4 Japan Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.5.5 South Korea Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.5.6 Southeast Asia Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.5.7 India Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.5.8 Australia Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.6 Latin America Pain Therapeutic Injectables Market Status by Country (2021-2026)

5.6.1 Latin America Pain Therapeutic Injectables Sales Volume by Country (2021-2026)

5.6.2 Latin America Pain Therapeutic Injectables Revenue by Country (2021-2026)

5.6.3 Mexico Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.6.4 Brazil Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.7 Middle East and Africa Pain Therapeutic Injectables Market Status by Country (2021-2026)

5.7.1 Middle East and Africa Pain Therapeutic Injectables Sales Volume by Country (2021-2026)

5.7.2 Middle East and Africa Pain Therapeutic Injectables Revenue by Country (2021-2026)

5.7.3 GCC Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

5.7.4 South Africa Pain Therapeutic Injectables Sales Volume, Revenue and Growth (2021-2026)

6 Global Pain Therapeutic Injectables Market Historical Development by Product Type (2021-2026)

6.1 Pain Therapeutic Injectables Definition by Type

6.2 Global Pain Therapeutic Injectables Historical Sales Volume by Product Type (2021-2026)

6.3 Global Pain Therapeutic Injectables Historical Revenue by Product Type (2021-2026)

6.4 Global Pain Therapeutic Injectables Historical Price by Product Type (2021-2026)

6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)

6.5.1 Global Pain Therapeutic Injectables Historical Sales Volume, Revenue and Growth Rate of OTC Products (2021-2026)

6.5.2 Global Pain Therapeutic Injectables Historical Sales Volume, Revenue and Growth Rate of Prescription Drugs (2021-2026)

7 Global Pain Therapeutic Injectables Market Historical Development by End User (2021-2026)

7.1 Downstream Market Overview

7.2 Global Pain Therapeutic Injectables Historical Sales Volume by End User (2021-2026)

7.3 Global Pain Therapeutic Injectables Historical Revenue by End User (2021-2026)

7.4 Global Pain Therapeutic Injectables Historical Price by End User (2021-2026)

7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)

7.5.1 Global Pain Therapeutic Injectables Historical Sales Volume, Revenue and Growth Rate of Hospital Pharmacies (2021-2026)

7.5.2 Global Pain Therapeutic Injectables Historical Sales Volume, Revenue and Growth Rate of Specialty Clinics (2021-2026)

7.5.3 Global Pain Therapeutic Injectables Historical Sales Volume, Revenue and Growth Rate of Long Term Care Centers (2021-2026)

7.5.4 Global Pain Therapeutic Injectables Historical Sales Volume, Revenue and Growth Rate of Retail Pharmacies (2021-2026)

7.5.5 Global Pain Therapeutic Injectables Historical Sales Volume, Revenue and Growth Rate of Drug Stores (2021-2026)

7.5.6 Global Pain Therapeutic Injectables Historical Sales Volume, Revenue and Growth Rate of Online Pharmacies (2021-2026)

8 Leading Companies Profiles

8.1 Cardinal Health

8.1.1 Cardinal Health Corporation Information

8.1.2 Cardinal Health - Pain Therapeutic Injectables Product Portfolio and Specification

8.1.3 Cardinal Health Performance Analysis (2021-2026)

8.1.4 Cardinal Health Business and Markets Served

8.1.5 Cardinal Health Recent Developments

8.2 Viatris

8.2.1 Viatris Corporation Information

8.2.2 Viatris - Pain Therapeutic Injectables Product Portfolio and Specification

8.2.3 Viatris Performance Analysis (2021-2026)

8.2.4 Viatris Business and Markets Served

8.2.5 Viatris Recent Developments

8.3 Boehringer Ingelheim International GmbH

8.3.1 Boehringer Ingelheim International GmbH Corporation Information

8.3.2 Boehringer Ingelheim International GmbH - Pain Therapeutic Injectables Product Portfolio and Specification

8.3.3 Boehringer Ingelheim International GmbH Performance Analysis (2021-2026)

8.3.4 Boehringer Ingelheim International GmbH Business and Markets Served

8.3.5 Boehringer Ingelheim International GmbH Recent Developments

8.4 Bausch Health Companies Inc.

8.4.1 Bausch Health Companies Inc. Corporation Information

8.4.2 Bausch Health Companies Inc. - Pain Therapeutic Injectables Product Portfolio and Specification

8.4.3 Bausch Health Companies Inc. Performance Analysis (2021-2026)

8.4.4 Bausch Health Companies Inc. Business and Markets Served

8.4.5 Bausch Health Companies Inc. Recent Developments

8.5 Perrigo Company Plc.

8.5.1 Perrigo Company Plc. Corporation Information

8.5.2 Perrigo Company Plc. - Pain Therapeutic Injectables Product Portfolio and Specification

8.5.3 Perrigo Company Plc. Performance Analysis (2021-2026)

8.5.4 Perrigo Company Plc. Business and Markets Served

8.5.5 Perrigo Company Plc. Recent Developments

8.6 Sanofi S.A.

8.6.1 Sanofi S.A. Corporation Information

8.6.2 Sanofi S.A. - Pain Therapeutic Injectables Product Portfolio and Specification

8.6.3 Sanofi S.A. Performance Analysis (2021-2026)

8.6.4 Sanofi S.A. Business and Markets Served

8.6.5 Sanofi S.A. Recent Developments

8.7 Novartis AG

8.7.1 Novartis AG Corporation Information

8.7.2 Novartis AG - Pain Therapeutic Injectables Product Portfolio and Specification

8.7.3 Novartis AG Performance Analysis (2021-2026)

8.7.4 Novartis AG Business and Markets Served

8.7.5 Novartis AG Recent Developments

8.8 Purdue Pharmaceuticals L.P.

8.8.1 Purdue Pharmaceuticals L.P. Corporation Information

8.8.2 Purdue Pharmaceuticals L.P. - Pain Therapeutic Injectables Product Portfolio and Specification

8.8.3 Purdue Pharmaceuticals L.P. Performance Analysis (2021-2026)

8.8.4 Purdue Pharmaceuticals L.P. Business and Markets Served

8.8.5 Purdue Pharmaceuticals L.P. Recent Developments

8.9 Procter & Gamble

8.9.1 Procter & Gamble Corporation Information

8.9.2 Procter & Gamble - Pain Therapeutic Injectables Product Portfolio and Specification

8.9.3 Procter & Gamble Performance Analysis (2021-2026)

8.9.4 Procter & Gamble Business and Markets Served

8.9.5 Procter & Gamble Recent Developments

8.10 AstraZeneca

8.10.1 AstraZeneca Corporation Information

8.10.2 AstraZeneca - Pain Therapeutic Injectables Product Portfolio and Specification

8.10.3 AstraZeneca Performance Analysis (2021-2026)

8.10.4 AstraZeneca Business and Markets Served

8.10.5 AstraZeneca Recent Developments

8.11 Bristol Myers Squibb Co.

8.11.1 Bristol Myers Squibb Co. Corporation Information

8.11.2 Bristol Myers Squibb Co. - Pain Therapeutic Injectables Product Portfolio and Specification

8.11.3 Bristol Myers Squibb Co. Performance Analysis (2021-2026)

8.11.4 Bristol Myers Squibb Co. Business and Markets Served

8.11.5 Bristol Myers Squibb Co. Recent Developments

8.12 GSK plc.

8.12.1 GSK plc. Corporation Information

8.12.2 GSK plc. - Pain Therapeutic Injectables Product Portfolio and Specification

8.12.3 GSK plc. Performance Analysis (2021-2026)

8.12.4 GSK plc. Business and Markets Served

8.12.5 GSK plc. Recent Developments

8.13 Sun Pharmaceutical Industries Ltd.

8.13.1 Sun Pharmaceutical Industries Ltd. Corporation Information

8.13.2 Sun Pharmaceutical Industries Ltd. - Pain Therapeutic Injectables Product Portfolio and Specification

8.13.3 Sun Pharmaceutical Industries Ltd. Performance Analysis (2021-2026)

8.13.4 Sun Pharmaceutical Industries Ltd. Business and Markets Served

8.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments

8.14 Amneal Pharmaceuticals

8.14.1 Amneal Pharmaceuticals Corporation Information

8.14.2 Amneal Pharmaceuticals - Pain Therapeutic Injectables Product Portfolio and Specification

8.14.3 Amneal Pharmaceuticals Performance Analysis (2021-2026)

8.14.4 Amneal Pharmaceuticals Business and Markets Served

8.14.5 Amneal Pharmaceuticals Recent Developments

8.15 Abbott Laboratories, Inc.

8.15.1 Abbott Laboratories, Inc. Corporation Information

8.15.2 Abbott Laboratories, Inc. - Pain Therapeutic Injectables Product Portfolio and Specification

8.15.3 Abbott Laboratories, Inc. Performance Analysis (2021-2026)

8.15.4 Abbott Laboratories, Inc. Business and Markets Served

8.15.5 Abbott Laboratories, Inc. Recent Developments

8.16 Teva Pharmaceuticals Ltd.

8.16.1 Teva Pharmaceuticals Ltd. Corporation Information

8.16.2 Teva Pharmaceuticals Ltd. - Pain Therapeutic Injectables Product Portfolio and Specification

8.16.3 Teva Pharmaceuticals Ltd. Performance Analysis (2021-2026)

8.16.4 Teva Pharmaceuticals Ltd. Business and Markets Served

8.16.5 Teva Pharmaceuticals Ltd. Recent Developments

8.17 Pfizer Inc.

8.17.1 Pfizer Inc. Corporation Information

8.17.2 Pfizer Inc. - Pain Therapeutic Injectables Product Portfolio and Specification

8.17.3 Pfizer Inc. Performance Analysis (2021-2026)

8.17.4 Pfizer Inc. Business and Markets Served

8.17.5 Pfizer Inc. Recent Developments

8.18 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)

8.18.1 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Corporation Information

8.18.2 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) - Pain Therapeutic Injectables Product Portfolio and Specification

8.18.3 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Performance Analysis (2021-2026)

8.18.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business and Markets Served

8.18.5 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Developments

8.19 AbbVie Inc. (Allergan plc)

8.19.1 AbbVie Inc. (Allergan plc) Corporation Information

8.19.2 AbbVie Inc. (Allergan plc) - Pain Therapeutic Injectables Product Portfolio and Specification

8.19.3 AbbVie Inc. (Allergan plc) Performance Analysis (2021-2026)

8.19.4 AbbVie Inc. (Allergan plc) Business and Markets Served

8.19.5 AbbVie Inc. (Allergan plc) Recent Developments

8.20 Endo Pharmaceuticals Inc.

8.20.1 Endo Pharmaceuticals Inc. Corporation Information

8.20.2 Endo Pharmaceuticals Inc. - Pain Therapeutic Injectables Product Portfolio and Specification

8.20.3 Endo Pharmaceuticals Inc. Performance Analysis (2021-2026)

8.20.4 Endo Pharmaceuticals Inc. Business and Markets Served

8.20.5 Endo Pharmaceuticals Inc. Recent Developments

8.21 F. Hoffmann-La Roche Ltd.

8.21.1 F. Hoffmann-La Roche Ltd. Corporation Information

8.21.2 F. Hoffmann-La Roche Ltd. - Pain Therapeutic Injectables Product Portfolio and Specification

8.21.3 F. Hoffmann-La Roche Ltd. Performance Analysis (2021-2026)

8.21.4 F. Hoffmann-La Roche Ltd. Business and Markets Served

8.21.5 F. Hoffmann-La Roche Ltd. Recent Developments

8.22 Bayer AG

8.22.1 Bayer AG Corporation Information

8.22.2 Bayer AG - Pain Therapeutic Injectables Product Portfolio and Specification

8.22.3 Bayer AG Performance Analysis (2021-2026)

8.22.4 Bayer AG Business and Markets Served

8.22.5 Bayer AG Recent Developments

8.23 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)

8.23.1 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Corporation Information

8.23.2 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) - Pain Therapeutic Injectables Product Portfolio and Specification

8.23.3 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Performance Analysis (2021-2026)

8.23.4 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business and Markets Served

8.23.5 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Developments

8.24 Mallinckrodt Pharmaceuticals

8.24.1 Mallinckrodt Pharmaceuticals Corporation Information

8.24.2 Mallinckrodt Pharmaceuticals - Pain Therapeutic Injectables Product Portfolio and Specification

8.24.3 Mallinckrodt Pharmaceuticals Performance Analysis (2021-2026)

8.24.4 Mallinckrodt Pharmaceuticals Business and Markets Served

8.24.5 Mallinckrodt Pharmaceuticals Recent Developments

9 Global Pain Therapeutic Injectables Market Forecast by Product Type and End User (2026-2034)

9.1 Global Pain Therapeutic Injectables Market Forecast by Product Type (2026-2034)

9.1.1 Global Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth Rate of OTC Products (2026-2034)

9.1.2 Global Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth Rate of Prescription Drugs (2026-2034)

9.2 Global Pain Therapeutic Injectables Market Forecast by End User (2026-2034)

9.2.1 Global Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth Rate of Hospital Pharmacies (2026-2034)

9.2.2 Global Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth Rate of Specialty Clinics (2026-2034)

9.2.3 Global Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth Rate of Long Term Care Centers (2026-2034)

9.2.4 Global Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth Rate of Retail Pharmacies (2026-2034)

9.2.5 Global Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth Rate of Drug Stores (2026-2034)

9.2.6 Global Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth Rate of Online Pharmacies (2026-2034)

10 Global Pain Therapeutic Injectables Market Forecast by Geographic Region (2026-2034)

10.1 Global Pain Therapeutic Injectables Sales Volume and Revenue Forecast by Geographic Region (2026-2034)

10.2 North America Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.1 United States Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.2.2 Canada Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3 Europe Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.1 Germany Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.2 France Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.3 United Kingdom Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.4 Spain Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.5 Russia Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.3.6 Poland Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4 Asia Pacific Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.1 China Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.2 Japan Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.3 South Korea Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.4 Southeast Asia Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.5 India Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.4.6 Australia Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5 Latin America Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.1 Mexico Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.5.2 Brazil Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6 Middle East and Africa Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.1 GCC Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

10.6.2 South Africa Pain Therapeutic Injectables Sales Volume, Revenue Forecast and Growth (2026-2034)

11 Appendix

11.1 Methodology

11.2 Research Data Source

11.2.1 Secondary Data

11.2.2 Primary Data

11.2.3 Market Size Estimation

11.2.4 Legal Disclaimer

Download FREE Sample

Security Code Captcha